Discover trends, market shifts, and competitive outlooks for the theranostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Theranostics Market, and What Factors Will Drive It?

The market size of theranostics has witnessed accelerated growth lately. The market is projected to propel from $111.1 billion in 2024 to $123.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.0%. Progressions in molecular imaging, a transition to a value-based healthcare system, and integration in the field of oncology have driven the growth experienced during the historic period.

The theranostics market is anticipated to witness significant expansion in the upcoming years, with expectations to reach “$185.73 billion by 2029, growing at a compound annual rate (CAGR) of 10.8%. The notable increase expected in the forecast period is mainly due to the surge in precision medicine initiatives, widening scope beyond oncology, an aging population with chronic diseases, improvements in biomarker discovery, along with government encouragement and financial backing. Upcoming trends for this forecast period encompass regulatory encouragement, rising popularity of companion diagnostics, heightened emphasis on cancer theranostics, improved patient involvement and awareness, and technological integration.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Theranostics Market?

The theranostics market is poised for growth, fueled by the increasing incidence of cancer. This life-threatening disease occurs when there is an uncontrolled growth of cells, affecting numerous organs and causing substantial global morbidity and mortality. Theranostics, an amalgamation of therapeutic and diagnostic techniques, holds immense potential in managing cancer and other chronic diseases. It fosters personalized, targeted treatments by integrating diagnostic and therapeutic capabilities, thus fostering innovation in health care. Consequently, the surge in cancer patients contributes to the expansion of the theranostics market. For instance, the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) in the US, reported in January 2022 that about 5.4% of the population, or 18.1 million people, are living as cancer survivors. Furthermore, about 623,405 individuals were living with metastatic carcinomas of the breast, prostate, lung, colorectum or bladder, or metastatic melanoma in 2022. This figure is anticipated to climb to 693,452 by 2025. Thus, the growing incidence of cancer substantiates the driving force behind the theranostics market’s growth.

Which Primary Segments of the Theranostics Market Are Driving Growth and Industry Transformations?

The theranostics market covered in this report is segmented –

1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases

2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Other Neurological Disorders

2) By Cardiovascular Diseases: Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Hypertension, Other Cardiovascular Diseases

3) By Immunological Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Psoriasis, Other Immunological Disorders

4) By Oncology Diseases: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Oncology Diseases

5) By Other Diseases: Infectious Diseases, Metabolic Disorders, Genetic Disorders, Other Diseases

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Theranostics Market?# Market?

North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Theranostics Market?

Key players involved in the theranostics market are prioritizing the development of technologically advanced strategies like theranostics clinical trials. The goal of these advancements is to augment personalized medicine and optimize patient results by incorporating diagnostics and therapeutics into a single methodology. Theranostics clinical trials are research endeavors that assess the simultaneous deployment of diagnostic tests and targeted therapies to customize treatments for specific patients. These trials strive to identify the effectiveness of designated treatments according to distinct patient biomarkers, thereby augmenting personalized medicine. For example, BAMF Health, a US-based cancer treatment institution, initiated the COMBAT Trial in May 2024, officially denoted as “A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617” (NCT05633160). The trial featured a swift activation process through BAMF Health’s BAMF RapAct program, allowing the trial to become operational in merely seven weeks. Consequently, the trial emphasized the use of cutting-edge radiopharmaceuticals targeting the Gastrin-Releasing Peptide receptor (GRPR) to expand treatment alternatives for patients with fewer therapeutic opportunities.

View the full report here:

https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

What Parameters Are Used to Define the Theranostics Market?

Theranostics is a medical field combining therapeutics and diagnostics into a single, integrated approach. It involves developing and applying diagnostic tests that not only detect diseases or conditions but also provide information to guide personalized therapeutic interventions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model